Development of nanoparticulate formulation of coenzyme Q10 and comparison of plasma coenzyme Q10 response in a single supplementation with regular coenzyme Q10 using rats

Journal of the Korean Society for Applied Biological Chemistry

Volumn 55, Issue 5, 2012, Pages 619-623

  Ok, Hyang Mok ^a   Kim, Sang Mi ^a   Park, Joo Won ^b   Kim, Kab Sig ^b   Nam, Han Kyul ^c   Kim, Ji Yeon ^d   Kwon, Oran ^a  

^a Ewha Womans University   (South Korea)

^b Bio Synetics   (South Korea)

^c Kyungbok Girl's High School   (South Korea)

^d Seoul National University of Science and Technology   (South Korea)

Author keywords

bioavailability; coenzyme Q10; nanoparticulate; stability

Indexed keywords

RATTUS;

EID: 84868308025     PISSN: 17382203     EISSN: 2234344X     Source Type: Journal    
DOI: 10.1007/s13765-012-2037-1     Document Type: Article

References (31)

1. Bhagavan HN and Chora RK (2006) Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res40, 445-453.
2. Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA et al. (2008) Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Part Fibre Toxicol5, 14.
3. Bouchemal K, Briançon S, Perrier E, and Fessi H (2004) Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int J Pharm280, 241-251.
4. Chopra RK, Goldman R, Sinatra ST, and Bhagavan HN (1998) Relative bioavailability of coenzyme Q10 formulations in human subjects. Int J Vitam Nutr Res68, 109-113.
5. Dhanasekaran M and Ren J (2005) The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res2, 447-459.
6. Dollo G, Le Corre P, Guérin A, Chevanne F, Burgot JL, and Leverge R (2003) Spray-dried redispersible oil-in-water emulsion to improve oral bioavailability of poorly soluble drugs. Eur J Pharm Sci19, 273-280.
7. Gallardo V, Morales ME, Ruiz MA, and Delgado AV (2005) An experimental investigation of the stability of ethylcellulose latex: correlation between zeta potential and sedimentation. Eur J Pharm Sci26, 170-175.
8. Hatanaka J, Kimura Y, Lai-Fu Z, Onoue S, and Yamada S (2008) Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations. Int J Pharm363, 112-117.
9. Illés E and Tombácz E (2006) The effect of humic acid adsorption on pHdependent surface charging and aggregation of magnetite nanoparticles. J Colloid Interface Sci295, 115-123.
10. Jang DJ, Jeong EJ, Lee HM, Kim BC, Lim SJ, and Kim CK (2006) Improvement of bioavailability and photostability of amlodipine using redispersible dry emulsion. Eur J Pharm Sci28, 405-411.
11. Joshi SS, Sawant SV, Shedge A, and Halpner AD (2003) Comparative bioavailability of two novel coenzyme Q10 preparations in humans. Int J Clin Pharmacol Ther41, 42-48.
12. Kaikkonen J, Nyyssönen K, Tuomainen TP, Ristonmaa U, and Salonen JT (1999) Determinants of plasma coenzyme Q10 in humans. FEBS Lett443, 163-166.
13. Kaikkonen J, Tuomainen TP, Nyyssonen K, and Salonen JT (2002) Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels. Free Radic Res36, 389-397.
14. Khandavilli S and Panchagnula R (2007) Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. J Invest Dermatol127, 154-162.
15. Kommuru TR, Gurley B, Khan MA, and Reddy IK (2001) Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm212, 233-246.
16. Kurowska EM, Dresser G, Deutsch L, Bassoo E, and Freeman DJ (2003) Relative bioavailability and antioxidant potential of two coenzyme q10 preparations. Ann Nutr Metab47, 16-21.
17. Mady MM and Darwish MM (2010) Effect of chitosan coating on the characteristics of DPPC liposomes J Adv Res1, 187-191.
18. Miles M, Horn P, Miles L, Tang P, Steele P, and DeGrauw T (2002) Bioequivalence of coenzyme Q10 from over-the-counter supplements. Nutr Res22, 919-929.
19. Mohanraj VJ and Chen Y (2006) Nanoparticles-a review. Trop J Pharm Res5, 561-573.
20. Mosqueira VC, Legrand P, Pinto-Alphandary H, Puisieux F, and Barratt G (2000) Poly(D, L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties. J Pharm Sci89, 614-626.
21. Nishimura A, Yanagawa H, Fujikawa N, Akiko K, and Nobuhito S (2009) Pharmacokinetic Profiles of Coenzyme Q10: Absorption of Three Different Oral Formulations in Rats. J Health Sci55, 540-548.
22. Nukui K, Yamagishi T, Miyawaki H, Kettawan A, Okamoto T, and Sato K (2007) Comparison of uptake between PureSorb-Q40 and regular hydrophobic coenzyme Q10 in rats and humans after single oral intake. J Nutr Sci Vitaminol (Tokyo)53, 187-190.
23. Prosek M, Butinar J, Lukanc B, Fir MM, Milivojevic L, Krizman M et al. (2008) Bioavailability of water-soluble CoQ10 in beagle dogs. J Pharm Biomed Anal47, 918-922.
24. Purchas RW, Busboom JR, and Wilkinson BH (2006) Changes in the forms of iron and in concentrations of taurine, carnosine, coenzyme Q(10), and creatine in beef longissimus muscle with cooking and simulated stomach and duodenal digestion. Meat Sci74, 443-449.
25. Sarker DK (2005) Engineering of nanoemulsions for drug delivery. Curr Drug Deliv2, 297-310.
26. Schulz C, Obermüller-Jevic UC, Hasselwander O, Bernhardt J, and Biesalski HK (2006) Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10). Int J Food Sci Nutr57, 546-555.
27. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, and Ali M (2007) Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm66, 227-243.
28. Siekmann B and Westesen K (1995) Preparation and physicochemical characterization of aqueous dispersions of coenzyme Q10 nanoparticles. Pharm Res12, 201-208.
29. Singh KK and Vingkar SK (2008) Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. Int J Pharm347, 136-143.
30. Tomono Y, Hasegawa J, Seki T, Motegi K, and Morishita N (1986) Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man. Int J Clin Pharmacol Ther Toxicol24, 536-541.
31. Vyas TK, Shahiwala A, and Amiji MM (2008) Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm347, 93-101.